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The development of mucosal immunity is presumed to be the most important marker of rotavirus infection.
The practical difficulties of obtaining small-bowel secretions stimulated this study of the antibody response to
acute rotavirus infection at other sites. Forty-four infants admitted to the hospital with rotavirus gastroenteritis
had serum, saliva, and feces collected at the acute phase (median, 5.5 days), during convalescence (median,
33.5 days), and 4 months later (median, 12.2 weeks). A subgroup of 19 children also had duodenal juice
collected in parallel. Rotavirus-specific immunoglobulin G (IgG), IgA, secretory immunoglobulin, and IgM
were measured and compared in all samples. The results showed that the estimation of antirotavirus serum
IgM, serum IgG, duodenal juice IgA, and duodenal juice IgM by an enzyme immunoassay indicated an
immune response to severe primary rotavirus infection in all children. Four months iater, the levels of serum
IgG and IgA served as the most sensitive markers of the preceding rotavirus infection. The predictive
accuracies of immune responses at different sites in relation to a positive IgA immune response in the duodenum
were calculated. Fecal IgA predicted duodenal IgA rotavirus antibodies with accuracies of 86% at 1 month and
92% at 4 months. The high sensitivity of serum IgM and IgG in detecting rotavirus infection and the high
predictive accuracy of fecal IgA as an indicator of duodenal IgA abrogates the need for duodenal intubation to
detect (or monitor) an immune response to rotavirus infection. This finding has important practical
implications for epidemiological studies of acute diarrhea in children and in rotavirus vaccine trials.
Rotaviruses are the single most common cause of severe
acute diarrhea in infants and young children. The mortality
and morbidity associated with infection in developing and
developed countries have led to the recognition of the need
for an effective rotavirus vaccine (15). Rotaviruses infect
mature epithelial cells lining the upper portions of the villi of
the small intestine (5), and antibodies present in the intesti-
nal lumen have been shown to play a primary role in passive
protection of young animals (18, 22).
It is assumed that antibodies produced by cells in the gut
mucosa in response to infection and secreted into the gut
lumen are the most important markers of an immune re-
sponse. However, it is not clear whether the immune re-
sponse can be detected equally well in serum and in gut
secretions. Initial assessments of candidate oral rotavirus
vaccines have used an enzyme immunoassay (EIA) of serum
antibodies to detect immune responses (15, 26), even though
animal experiments have indicated that serum antibody
levels generally cannot be correlated with protection (18,
22). Studies of the immune response to natural infection in
young children have mainly focused on the measurement of
rotavirus antibodies in serum or in feces (8, 12, 19, 20, 23,
24). Two studies have measured rotavirus antibodies in small
intestinal secretions (6, 13). Davidson et al. (6) compared
immunoglobulin M (IgM), IgG, and IgA antirotavirus anti-
body responses in serum and duodenal juice obtained from
eight children (2 to 24 months old) at 1 week and 4 to 5 weeks
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after the onset of infection. Hjelt et al. (13) compared IgG,
IgA, and secretory immunoglobulin antirotavirus antibody
responses in serum, duodenal juice, and feces obtained from
eight children (36 days to 7.2 years old) 1 to 2 days and 5 to
9 days postadmission to the hospital with rotavirus gastroen-
teritis. The results of both studies combined indicate that
specific IgM, IgA, and secretory immunoglobulin in serum
from some children may show patterns of response identical
to those measured simultaneously in intestinal secretions.
The aim of this study was to document in the most
comprehensive manner possible the development and per-
sistence of rotavirus IgG, IgM, IgA, and secretory immuno-
globulin antibodies in serum and secretions (saliva, duodenal
juice, and feces) obtained simultaneously from infants and
young children following severe acute rotavirus infection. In
particular, the study was designed to determine the speci-
men(s) and the assay(s) best suited to the detection of an
immune response to rotavirus infection. The results show
that EIA measurement of antirotavirus IgM or IgG antibod-
ies in sera obtained 7 and 30 days after the onset of
symptoms is a reliable indicator of a recent rotavirus infec-
tion. In addition, the presence of antirotavirus IgA in stools
4 weeks after infection indicates the presence of the same
antibody in duodenal fluid, with a predictive accuracy of
86%.
MATERIALS AND METHODS
Patients. Patients were 44 children (26 male), 3 weeks to 39
months old, admitted to the infectious diseases ward of the
Royal Children's Hospital, Melbourne, Victoria, Australia,
with acute rotavirus diarrhea (less than 6 days from onset)
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SERUM AND MUCOSAL ROTAVIRUS ANTIBODIES 733
between April 1984 and September 1985. Vomiting was
present in all children, and 42 had fever. Dehydration was
assessed as 5% (16 children), 6 to 9% (15 childreni, or .10%
(13 children), and parenteral rehydration was undertaken in
28 of 44 children. The duration of symptoms was 4 to 13 days
(median, 6 days), and hospitalization occurred for a median
of 4 days (range, 2 to 13 days). Recovery in five children was
complicated by the development of sugar malabsorption.
Patients were divided into two groups with similar demo-
graphic and clinical features. Group A comprised 19 children
(11 male), 2 to 39 months old (mean, 19.5 months), from
whom saliva, duodenal juice, feces, and serum were col-
lected. Group B comprised 25 children (15 male), 0.75 to 36
months old (mean, 16 months), from whom saliva, feces, and
serum were collected. None of the children were breast-fed
during the course of the study.
Rotavirus infection was diagnosed within a few hours of
admission to the hospital by electron microscopy of nega-
tively stained concentrated fecal homogenates. Results were
confirmed by an EIA with monoclonal antibodies developed
in our laboratory to identify group and serotype antigens (4).
A total of 27 children were infected with serotype 1 rotavi-
ruses, and 10 were infected with serotype 4 rotaviruses. No
serotype could be assigned to rotaviruses infecting seven of
the children.
Ethical approval for the study was obtained from the
Human Ethics Committees of the Royal Children's Hospital
and of the World Health Organization. Informed consent
was obtained from the parents of the children prior to
enrollment in the study.
Sample collection. Three specimens each of blood, saliva,
and feces were collected from the 44 children studied. In
addition, three specimens of duodenal juice were collected
from the 19 children in group A. The sets of specimens from
each child were collected at 2 to 7 days (median, 5.5 days),
24 to 66 days (median, 33.5 days), and 100 to 282 days
(median, 122 days) after the onset of symptoms. Although
collection intervals varied from child to child, for each
individual child the sets of specimens (serum and secretions)
were collected on the same day. Additional fecal specimens
were collected daily while each child was in the hospital and
weekly thereafter for the duration of the study. Blood
specimens were collected by venipuncture or finger pricking.
Blood was allowed to clot at room temperature, centrifuged
at 750 x g for 5 min, and stored at -70°C. Unstimulated
whole saliva was obtained by placing rolls of cotton gauze in
the mouth between the cheek and clenched teeth, close to
the opening of the parotid ducts. When moist, the rolls were
removed, and the sublingual pool of saliva was also col-
lected. The gauze rolls were centrifuged at 3,000 rpm for 5
min, and the saliva was stored at -70°C. Feces were
collected and stored at -70°C within 4 h if collected in the
hospital. Feces collected at home were immediately stored
at -20°C initially, transferred to the hospital in a car freezer,
and then stored at -70°C. Duodenal juice was collected in
the hospital by using the technique described by Ford (7).
Children fasted and were premedicated with oral quinalbar-
bitone (12 mg/kg) and metoclopramide (0.2 mg/kg). Once the
child was sedated, a Watson pediatric intestinal biopsy
capsule (minus the knife block) with an attached French
five-gauge feeding tube was introduced, and progress to the
third or fourth part of the duodenum was monitored by
fluoroscopy. Small portions of air were instilled via the
biopsy capsule tube to encourage aspiration of fluid up the
feeding tube. Duodenal fluid (5 to 10 ml) was aspirated within
5 min, immediately centrifuged at 750 x g for 5 min, and
stored at -70°C. Following duodenal aspiration all children
were observed in a recovery room for 2 to 4 h until awake.
Antibody assays. Serum, saliva, duodenal juice, and feces
were all examined for the presence of rotavirus antibodies by
an EIA modified to quantitate class-specific antibodies (IgA,
IgM, and IgG) and secretory immunoglobulin. IgA, IgG, and
secretory immunoglobulin in all specimens and IgM in
saliva, duodenal juice, and feces were measured by modifi-
cations of a direct EIA (2, 4). IgM in serum was measured by
a capture EIA.
Briefly, the technique of direct EIA involved coating
microdilution trays with SA11 antigen (grown in MA104
cells), followed by the addition of a sample of serum, saliva,
duodenal juice, or fecal homogenate. After the trays were
washed, specific antibody was detected by using rabbit
antihuman IgA, secretory immunoglobulin, IgM, or IgG
conjugated to horseradish peroxidase (DAKO Immunoglob-
ulins) and by using 3,3',5,5'-tetramethyl benzidine (TMB)
substrate. The optical density at 450 nm was measured by
using a Titertek EIA reader. All samples were assayed in
duplicate against SA11 antigen and against uninfected
MA104 celis as the control antigen. The specificity of the
reaction was controlled by including wells containing SA11
or control antigen incubated in the absence of the sample.
Sensitivity was checked by including wells containing SA11
or control antigen incubated in the presence of samples
known to contain high titers of a particular rotavirus-specific
immunoglobulin class. A test well was considered positive if
its optical density at 450 nm was greater than or equal to two
times that of its own control. The capture technique used for
the serum IgM assay included affinity-purified goat antihu-
man IgM (TAGO Immunoglobulins) as the initial coating on
the microdilution plates. Serial doubling dilutions of each
test serum specimen (beginning at 1:50) were added. After
the plates were washed, SA11 and MA104 cells were added
to test and control wells for each serum specimen. The plates
were washed again, and monoclonal antibody to rotavirus
group antigen (developed in our laboratory) conjugated to
horseradish peroxidase was added, followed by TMB sub-
strate. The sensitivity and specificity of the assay were
checked by the inclusion of known positive and negative
specimens. No rheumatoid factor was detected in any of the
serum specimens by latex agglutination with RapiTex R.F.
(Behring Institute).
Rotavirus antibodies of each class were quantitated by
endpoint titrations by using doubling dilutions. The posi-
tive/negative (P/N) cutoff values established for each immu-
noglobulin class at each site are shown in Fig. 1. The data
establishing these values will be published elsewhere. An
immune response for IgA, secretory immunoglobulin, and
IgG was defined as a fourfold increase in titer in two
consecutive specimens such that the maximum value was
greater than or equal to two times the P/N value. An immune
response for IgM was defined as a titer greater than or equal
to two times the P/N value in a single specimen.
Statistical methodology. The major statistical tests used
were the McNemar test for correlated proportions and a
generalization of the Wilcoxon signed-rank test (21). These
tests allowed pairwise and multiple comparisons to be made
between different antibodies at a given site and between
different sites for the same antibody by using, respectively,
the proportions of elevated immune antibody response (Mc-
Nemar test) and the actual antibody titers or the logarithmic
(to the base 2) antibody titers (Wilcoxon-type test). The
reliability of extraintestinal sites as indirect measures of
immune response in the small intestine was tested by assess-
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FIG. 1. Rotavirus antibody titers in serum and intestinal contents after rotavirus enteritis in infants during the acute phase (A), during the
convalescent phase (C), and after 4 months (4/12). M, Median value. Horizontal lines represent P/N cutoff values. Vertical lines represent
ranges of values. scIg, Secretory immunoglobulin.
ments of sensitivity and positive predictive accuracy. The
Kendall tau value (16) was calculated to assess the associa-
tion between antibody titers in duodenal fluid and other
sites. All statistical computations were carried out by using
the Minitab (Minitab Manual, 1985) and custom-written
Minitab macros.
RESULTS
Occurrence of immune response during month 1 after
infection. The percentages of patients demonstrating antiro-
tavirus immune responses in duodenal juice, saliva, feces,
and serum are shown in Table 1. The total number of
patients showing an immune response in at least one sub-
class of antibody at each site sampled is also shown, since
many patients showed an immune response in more than one
subclass of antibody. The medians and ranges of values for
each immunoglobulin class in each specimen are shown in
Fig. 1.
All patients studied showed an immune response in duo-
denal juice. The dominant antibody responses were in IgA
(84%) and IgM (84%). An immune conversion to secretory
immunoglobulin was detected in 58% of patients and was
always associated with a response in IgA or IgM antibody
(or both). IgG responses were seldom detected (26%). An
immune response (predominantly in IgA and IgM antibodies)
was observed in saliva and feces from 80 and 84% of
patients, respectively. Titers of all antibody subclasses in
duodenal juice and saliva (Fig. 1) were low, ranging from
<1:12.5 to 1:800. Titers in feces were often high and ranged
from 1:50 to 1:25,600, with a median of 1:400 in convales-
cent-phase specimens. No IgG antibodies were detected in
feces from any children.
All children showed an IgM immune response in serum,
and 91% showed an IgG immune response. Only 3 of the 44
children (all older than 6 months) had elevated IgG titers in
acute-phase sera. Of the 44 children, 4 showed no serocon-
version to IgG antibodies. Three of these were aged 3
months or less. The fourth child had a high titer of IgG
antibodies in acute-phase serum (1:6,400) that did not rise
further. An IgA immune response in serum was detected in
68% of children, but secretory immune responses occurred
in only 14% of patients. The ages of patients who failed to
show an IgA immune response ranged from 2 to 37 months
(mean, 16.2 months).
Rotavirus antibody levels 4 months after infection. The
percentages of children with detectable levels of immuno-
globulin subclasses (greater than or equal to two times the
P/N cutoff values) at each of the four sites 4 months after
rotavirus gastroenteritis are listed in Table 2. Few children
showed detectable antirotavirus IgM antibodies at any site.
IgA antibodies were detected frequently in duodenal juice,
saliva, feces, and serum. The McNemar test for correlated
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TABLE 1. Immune responses in serum and mucosal sites following rotavirus gastroenteritis
a% of patients with immune response to:
Specimen No. of patients Total immune response
examined IgA Secretory (% of patients)IgA
~immunoglobulin IgM IgG
Duodenal fluid 19 84 58 84 26 100
Saliva 44 55 20 50 30 80
Feces 44 77 66 61 0 84
Serum 44 68 14 100 91 100
proportions showed that the IgA immune response 4 months
after rotavirus gastroenteritis was not significantly different
whether measured at the duodenal or fecal site (P > 0.10).
Pairwise comparisons of the median antibody titers (4
months after rotavirus gastroenteritis) done with the Wil-
coxon signed-rank test showed that median IgA antibody
titers in the duodenum were not significantly different from
median IgA antibody titers in feces (P > 0.10) and serum (P
> 0.80). The Maritz generalized Wilcoxon test for trends
showed that the IgA antibody titers were not significantly
different 4 months after rotavirus gastroenteritis in the
duodenum, feces, and serum (P > 0.05). IgG antibodies were
present in àll serum samples. Low positive levels of IgG
antibodies were detected in approximately 60% of saliva and
duodenal juice specimens. There was a statistically signifi-
cant association (P < 0.015) between IgG titers of .1:12,800
in serum and the detection of positive levels of antirotavirus
IgG (titer, .1:50) in acute- and convalescent-phase speci-
mens of saliva and duodenal juice.
Kinetics of response. The development and changes in
titers of rotavirus antibodies of each immunoglobulin sub-
class in duodenal juice (19 children) and saliva, feces, and
serum (44 children) are shown in Fig. 1. The P/N cutoff
values for antibody measurements are indicated.
For duodenal and saliva specimens, àntirotavirus IgA
titers were highest in specimens obtained approximately 30
days after onset and were also elevated in most children 4
months later. The earliest detection of antirotavirus IgM was
on day 4 after the onset of symptoms, but most positive
specimens were obtained on days 6 and 7 after onset.
Secretory immunoglobulin was detected in some patients
during the acute phase, increased in titer during convales-
cence, and remained elevated in titer 4 months later.
The collection of numerous fecal specimens from each
child allowed a closer examination of the timing of the
appearance of rotavirus antibodies. Rotavirus-specific IgA,
IgM, and secretory immunoglobulin appeared as early as day
3, reached maximum values between days 11 and 15, and
decreased to approximately P/N cutoff values by week 5.
The antirotavirus antibody responses in serum differed
from the secretory responses in saliva, duodenal juice, and
feces. Positive serum IgM levels were detected as early as
day 2 after onset, but the highest titers were generally found
in specimens obtained more than 6 days after onset. Serum
IgG and IgA titers reached maximum levels during conva-
lescence, and these were maintained with little change at 4
months. Median levels of IgG (1:6,400) in convalescent-
phase specimens and specimens taken at 4 months were
significantly different from median levels of IgA (1:400) (P <
0.0001).
Prediction of duodenal IgA response by responses at more
accessible sites. Assuming that the IgA immune response in
the duodenum is of critical importance, the data were
examined to assess the sensitivity and positive predictive
accuracy of responses at more accessible sites.
Sensitivity is a measure of the likelihood that a particular
site will show a positive response when the response in the
duodenum is known to be positive, e.g., if a test on speci-
mens from an extraduodenal site reveals a positive response
in 8 cases out of 10 in which the duodenal response is
positive, then the sensitivity of the test at that site is 80%.
Predictive accuracy is a measure of the likelihood that an
immune response known to be positive at an extraduodenal
site is associated with a positive immune response in the
duodenum; e.g., if an immune response at an extraduodenal
site in 10 cases is associated with an immune response in the
duodenum in 7 cases, the predictive accuracy of the test at
that site is 70%.
Tables 3 and 4 list these indices for immune conversion at
different sites at 4 weeks and for elevated antibody levels at
different sites at 4 months, respectively.
At 4 weeks, a serum IgM response was always found when
a duodenal IgA response occurred, i.e., the sensitivity of
serum IgM was 100%. The sensitivity of serum IgG was
87.5%. Four months after rotavirus infection, the sensitivity
of serum IgG and IgA as indicators of elevated duodenal IgA
antibodies was 100%. The most accurate predictors of a
duodenal IgA response during the first 4 weeks after onset
were salivary IgA (86%) and fecal IgA (86%). After 4
months, predictive accuracy was highest for fecal IgA (92%)
as compared with other sites. The Kendall tau value was
calculated to measure the association between IgA antibody
titers in duodenal fluid and in saliva, feces, and serum. There
was a significant association only between duodenal and
TABLE 2. Elevated specific antibodies in serum and mucosal sites 4 months after rotavirus gastroenteritis
a% of patients with positive antirotavirus antibody:
Specimen No. of patients Total positive antibody
examined Secretory (% of patients)IgA immunoglobulin IgM IgG
Duodenal fluid 19 79 74 32 63 79
Saliva 43 60 40 9 70 70
Feces 43 63 20 7 0 63
Serum 43 93 0 14 100 100
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fecal IgA antibody titers (Kendall tau, 0.392; P = 0.036). The
Kendall tau value for duodenal fluid and saliva was 0.091;
that for duodenal fluid and serum was 0.227. This test
indicates that only the IgA titers in duodenal fluid and feces
are concordant (P > 0.05).
DISCUSSION
Young children with rotavirus gastroenteritis severe
enough to warrant hospitalization simultaneously exhibited
specific antibody responses in duodenal fluid, saliva, feces,
and serum. The responses documented were probably char-
acteristic of responses to a primary rotavirus infection.
There are three reasons for this assumption. Firstly, all
children studied had severe symptoms, and it now seems
likely that in a particular child, only the first rotavirus
episode is associated with severe symptoms (1, 10). Sec-
ondly, the development of serum antibodies followed the
classical pattern of a primary infection, with early rises in
antirotavirus IgM antibodies. As corroborative evidence,
only 3 of the 44 children showed elevated serum antirota-
virus IgG titers in acute-phase sera. It is possible that in
these three children the antibodies may not have preceded
the onset of disease but may have represented a rapid and
disproportionate increase in the levels of IgG3 subclass
antibody, which has kinetic properties similar to those of
IgM (9). Finally, during longitudinal surveillance, many of
the children experienced further proven rotavirus infections,
but these were not associated with the development of serum
antirotavirus IgM (unpublished observations).
There was considerable variation in the immune responses
of individual children. These variations may have been due
to differences in the ages of the children or in the severity of
their illness or to minor differences in sampling times after
onset, as has been observed in calves (11, 25). The variable
responses detected in this study were not due to inaccuracies
inherent in the use of SA11 as an antigen in the assay system,
since the substitution of rotavirus serotypes 1 and 4, which
are homologous with the rotavirus serotypes excreted by
individual children, did not alter the results of the assays
(unpublished observations).
The isotypes involved most frequently in immune conver-
sions in duodénal juice, saliva, and feces were antirotavirus
IgM and IgA, even in the four infants who were less than 3
months old, confirming the results from other studies (6, 13,
19, 20, 23). Most increases in IgM were detected by days 6 to
7 after the onset of symptoms. The appearance of IgM in gut
secretions supports the belief that it may have a protective
role in the early elimination of antigens from mucosal
surfaces before thé development of an IgA immune response
(3). Peak titers of rotavirus-specific IgA were usually de-
TABLE 3. Sensitivity and predictive accuracy of immune
responses at different sites in relation to a positive IgA
immune response in the duodenum during the first
4 weeks after rotavirus infection
Site Immunoglobulin % Sensitivitya % Predictive accuracya
Serum G 87.5 (14/16) 82 (14/17)
A 62.5 (10/16) 83 (10/12)
M 100 (16/16) 84 (16/19)
Saliva A 75 (12/16) 86 (12/14)
Feces A 75 (12/16) 86 (12/14)
a Data in parentheses represent number positive/number tested.
TABLE 4. Sensitivity and predictive accuracy of elevated
antibody levels at different sites in relation to elevated duodenal
IgA levels 4 months after rotavirus infection
Site Immunoglobulin % Sensitivitya % Predictive accuracy
Serum G 100 (15/15) 79 (15/19)
A 100 (15/15) 79 (15/19)
Saliva A 73 (11/15) 85 (11/13)
Feces A 73 (11/15) 92 (11/12)
a See Table 3, footnote a.
tected in feces between days 11 and 15 after ônset. This may
explain why relatively low peak titers of rotavirus-specific
IgA were detected in duodenal contents sampled on days 5
to 7 (early) or days 28 to 35 (late) as compared with fecal
samples. The measurement of duodenal fluid secretory im-
mnunoglobulin was not as useful as the measurement of IgA
or IgM in the detection of an immune conversion after
rotavirus infection. Low titers of antirotavirus IgG were
detected in duodenal fluid from some children. These may
have been derived by passive transfer from serum (3), since
there was a statistically significant correlation (P < 0.01)
between IgG antibodies in duodenaljuice and the occurrence
of serum IgG antibody titers of .1:12,800. Rotavirus-spe-
cific fecal IgG antibodies were never detected in the present
study, even in the presence of rotavirus-specific IgG anti-
bodies in duodenal fluid and saliva. Partially degraded rota-
virus IgG coproantibodies have been reported in previous
studies (13, 23).
Immune conversions were observed with a similar fre-
quency of duodenal contents and in serum. Serum IgM and
IgG were more sensitive measures of response than was
serum IgA. Rotavirus-specific IgA responses have been less
well characterized than those of IgG. Hjelt et al. reported a
significant increase in IgA levels in serum in 10 of 12 patients
7 to 14 days after the onset of diarrhea, and 80% of samples
were positive after 6 months (12). IgG also persisted for
months in serum in their patients (8, 12). A total of 68% of
our patients showed an acute-phase serum IgA response,
and 93% had persisting antibody at 4 months. Hjelt et al. also
reported antirotavirus secretory immunoglobulin in 17 of 20
patients at 7 to 14 days that virtually disappeared by 1.6 to
3.0 months. In our study the early secretary immunoglobulin
response was very low (14%), and none of 43 sera were
positive at 4 months. Differences in the definition of secre-
tory immunoglobulin responses may account for these con-
flicting results. Our results do not support a role for serum
secretory immunoglobulin as a marker for a recent rotavirus
infection.
Only one of the four infants younger than 3 months
demonstrated an IgG seroconversion between acute- and
convalescent-phase specimens. However, when serum IgG
measurements were repeated 4 months later in these four
children, the expected fall in rotavirus antibody titer was not
observed. The development of serotype-specific neutralizing
antibodies could not be demonstrated (unpublished observa-
tions). This suggests that there was an initial active IgG
immune response that was obscured by the preexisting
maternally derived IgG. IgM seroconversions were detected
in all four infants, indicating the importance of measuring
IgM antibody in sera after a rotavirus infection in neonates
or young infants.
The isotypes most frequently detected 4 months after a
severe acute rotavirus infection were IgA in intestinal con-
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tents and IgA and IgG in serum. Coproantibodies detected in
some children 4 months after severe rotavirus gastroenteritis
may have been due to a relapse or to reinfection and not to
the persistence of these antibodies, as previously suggested
(8, 12, 13). Marked weekly fluctuations in rotavirus-specific
coproantibodies were observed in individual children, and
these were often associated with transient diarrhea (with or
without rotavirus excretion). These observations will be
discussed elsewhere in more detail. They lead to the conclu-
sion that the presence of rotavirus-specific IgA in feces 4
months after a rotavirus infection need not suggest the
persistence of antibody from the original infection but may
represent a response to repeated infection.
A recent paper studying cholera and toxigenic Escherichia
coli concluded that serum antibodies were the best indirect
measure of intestinal immunity after the clinical disease (14).
Having similarly documented the antibody responses at a
number of sites in children with rotavirus infections, we
found it possible to compare and to make judgements as to
whether measurements of rotavirus antibodies in an easily
accessible specimen such as serum, saliva, or feces would
accurately reflect the levels of antibodies secreted into the
small intestine at the site of infection. Although serum IgA
showed a high predictive accuracy at 1 and 4 months in
relation to duodenal IgA, the presence of rotavirus-specific
fecal IgA showed an even stronger correlation (P = 0.036) in
the children studied. This may indicate that a longitudinal
study of fluctuations in antirotavirus IgA coproantibodies
reflects the fluctuating production of antibodies in the small
intestine, perhaps in response to a recurrent asymptomatic
infection or to a persisting infection.
The results of this study indicate that estimations of
antirotavirus serum IgM and serum IgG are sensitive indi-
cators of an immune response to severe primary rotavirus
gastroenteritis and reflect the response in duodenal fluid. In
specimens taken 4 months later, the most reliable markers
for a previous rotavirus infection are serum IgG and serum
IgA. IgA coproantibody is a useful predictor of antirotavirus
IgA secretion in the duodenum. Thus, the measurement of
serum antibodies or coproantibodies accurately reflects du-
odenal antibodies, and there appears to be no advantage to
be gained by measuring duodenal fluid antibodies. This
removes the need for duodenal intubation to detect an
immune response to rotavirus infection. This advantage has
important practical implications for epidemiological studies
of acute diarrhea in children and in trials testing the immu-
nogenicity and efficacy of candidate rotavirus vaccines.
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